CDC: Life Expectancy for U.S. Population Increased in 2019
And age-adjusted rate of drug overdose deaths increased from 20.7 to 21.6 per 100,000 from 2018 to 2019
Risk for Severe COVID-19 Not Increased for Children With Cancer
In children with cancer younger than 16, the estimated incidence of hospital-identified SARS-CoV-2 infection was 3 percent
Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations
Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal
Early-Onset CRC Incidence Examined by Histologic Subtype
Adenocarcinomas increasing in most early-onset subgroups; carcinoid tumors increasing more steeply in all age groups
Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone
Integrated Palliative and Oncology Care Improves QOL in Leukemia
Those receiving IPC were more likely to report discussing end-of-life preferences, were less likely to receive chemo at end of life
Recurrence Risk Low After One Year of Watch-and-Wait for Rectal Cancer
Authors say these findings suggest no need for intensive surveillance after three years
Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i
UV Exposure Not Linked to Risk for Melanoma in Skin of Color
In 11 of 13 studies reviewed, no association observed between UV exposure, melanoma in skin of color
